Kinaxis is still a buy, Laurentian Bank says

Ahead of Kinaxis Inc.’s (Kinaxis Stock Quote, Chart, News: TSX:KXS) fourth quarter 2017 results due next week, analyst Nick Agostino of Laurentian Bank Securities says he’s focused on a number of variables for the supply chain software company, namely, how Q4 bears out Kinaxis’ subscription growth, professional services sales and its EBITDA margin.

“Beyond a potential Q4 positive read through regarding client wins, we need to see strong subscription growth and further EBITDA expansion to gain increased comfort on SI contributions,” says the analyst in a note to clients on Wednesday.

Agostino says he’s looking for subscription growth of 19 per cent, which would be a slowdown in comparison to rates posted over the last five quarters. The analyst expects the company’s EBITDA margin for Q4 to come in at 27.2 per cent and for Kinaxis’ sales and EBITDA to come in slightly ahead of consensus, with adjusted EPS of $0.22 (USD) and an estimated net cash at the end of Q4 of $160.9 million.

The Ottawa-based company saw its share price jump in January after it was revealed that the world’s number one auto maker, Toyota, would be signing up with Kinaxis’ RapidResponse supply chain management cloud-based software. Last year, the company confirmed both Nissan and Volvo as subscribers, as well.

Agostino has a “Buy” rating on KSX-T with an $88 (CDN) one-year target price, based on 9x 2018/2019 sales estimates, representing a 5.8 per cent return on investment as of publication date.

“We recognize a disconnect between our target price and recommendation following the 10% run-up in the shares post the Toyota contact announcement on January 23 as investors regained confidence in the company’s growth prospects,” says the analyst. “We will revisit our estimates, target price and recommendation post results.”

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: kxs
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is GOOGL still a buy?

Following a widely applauded first quarter beat, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Alphabet (Alphabet… [Read More]

1 hour ago

NLH has 173% upside, Echelon says

Following an acquisition, Echelon Capital Markets analyst Stefan Quenneville has maintained his "Buy" rating on Nova Leap Health (Nova Leap… [Read More]

2 hours ago

Shopify upgraded to “Buy” at Citi

The stock has been flat since November, but Citi analyst Tyler Radke thinks there is now money to be made… [Read More]

2 hours ago

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

3 days ago

Is SNAP a buy right now?

He feels the company made forward progress in its recent quarterly results, but Roth MKM analyst Rohit Kulkarni wants to… [Read More]

3 days ago

Bombardier wins price target raise at Desjardins

Following the company's first quarter results, Desjardins analyst Benoit Poirier has raised his price target on Bombardier (Bombardier Stock Quote,… [Read More]

3 days ago